Autoimmune liver diseases

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 61, Issue 235, 2001, Pages 53-60

  McFarlane, I G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autoantibodies; Autoimmune hepatitis; Chronic liver disease; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; BILIRUBIN; BIOCHEMICAL MARKER; CYTOCHROME P450 2D6; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY; PYRUVATE DEHYDROGENASE; AUTOANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SEROLOGY; BILIARY CIRRHOSIS; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; LIVER DISEASE; REVIEW; SCLEROSING CHOLANGITIS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; DIAGNOSIS, DIFFERENTIAL; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES;

EID: 0034740509     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis
2. Primary sclerosing cholangitis
3. Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules
4. Histopathology of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis
5. Immunological liver diseases in children
6. Management of primary biliary cirrhosis
7. Natural history of early primary biliary cirrhosis
8. Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis
9. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
10. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
11. Diagnostic criteria, clinical manifestations and natural history of primary sclerosing cholangitis
12. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors
13. The molecular genetics of autoimmune liver disease
14. Allelic sequence variation in the HLA Class II genes and proteins in patients with autoimmune hepatitis
15. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis
16. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis
17. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis
18. Immunogenetic studies of autoimmune hepatitis and primary sclerosing cholangitis
19. Immunogenetic studies of primary biliary cirrhosis
20. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis
21. TNF gene polymorphisms in primary biliary cirrhosis: A critical appraisal
22. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis
23. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis
24. Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeletal proteins
25. Specificities and clinical significance of anti-cytoskeleton antibodies in anti-smooth muscle antibody-positive patients with chronic liver disease C
26. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis
27. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection
28. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease
29. Overlapping but distinct specificities of anti liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes
30. Hepatocellular membrane antigens
31. The asialoglycoprotein receptor in autoimmune liver disease
32. Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies
33. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen
34. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis
35. Members of the glutathione-S-transferase gene family are antigens in autoimmune hepatitis
36. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
37. Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP((Ser)Sec) complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis
38. Lessons about antibodies in autoimmune hepatitis
39. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis
40. Argininosuccinate lyase: A new autoantigen in liver disease
41. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis
42. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection
43. Heterogeneity of antinuclear antibodies in autoimmune liver diseases
44. Antibodies to cytoskeleton antigens in autoimmune liver diseases
45. Autoantibodies against "nulcear dots" in primary biliary cirrhosis
46. Nuclear envelope protein autoantibodies in primary biliary cirrhosis
47. Antimitochondrial antibodies in primary biliary cirrhosis
48. PBC and AMA -What is the connection?
49. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential
50. Antineutrophil cytoplasmic and other autoantibodies in primary sclerosing cholangitis